Sumitomo Pharma Co., Ltd. (DNPUF)
OTCMKTS · Delayed Price · Currency is USD
10.99
0.00 (0.00%)
At close: Oct 29, 2025
Sumitomo Pharma Market Cap
Sumitomo Pharma has a market cap or net worth of $4.34 billion as of October 31, 2025. Its market cap has increased by 148.62% in one year.
Market Cap
4.34B
Enterprise Value
6.22B
Revenue
2.88B
Ranking
n/a
PE Ratio
33.14
Stock Price
$10.99
Market Cap Chart
Since January 14, 1992, Sumitomo Pharma's market cap has increased from 1.62B to 4.34B, an increase of 167.35%. That is a compound annual growth rate of 2.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 4.34B | 205.17% |
| Dec 30, 2024 | 1.42B | 8.36% |
| Dec 29, 2023 | 1.31B | -56.36% |
| Dec 30, 2022 | 3.01B | -34.17% |
| Dec 30, 2021 | 4.57B | -21.94% |
| Dec 30, 2020 | 5.86B | -24.66% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Elite Pharmaceuticals | 655.03M |
| Glass House Brands | 559.28M |
| Northwest Biotherapeutics | 355.88M |
| Silence Therapeutics | 345.28M |
| Nika Pharmaceuticals | 312.10M |
| CytoDyn | 303.60M |
| American Oncology Network | 302.09M |